Company Filing History:
Years Active: 2011-2013
Title: Te-Sheng Liang: Innovator in Cancer Treatment
Introduction
Te-Sheng Liang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Liang's work focuses on the development of radioactive materials that can effectively inhibit cancer.
Latest Patents
Liang's latest patents include a "Radioactive material containing chitosan for inhibiting cancer and preparation method thereof." This invention reveals a radioactive material formed by using a SOCTA chelating agent to connect chitosan with radionuclides such as Re and Tc-99m. The preparation method involves creating a SOCTA-Chitosan compound and subsequently forming an M(radionuclide)-SOCTA-Chitosan compound. The biocompatibility of chitosan allows the radioactive material to be injected into cancerous areas, providing effective treatment by remaining in the body for an extended period.
Another significant patent is the "Radioactive mixture and manufacturing method thereof." This invention discloses a radioactive mixture formed through a chelating reaction of MN series compounds with TcO or ReO, which is then dissolved in Lipiodol. This mixture is designed to treat liver cancers, breast cancers, and other solid tumors while minimizing injuries caused by surgical operations. The innovative use of Lipiodol allows the mixture to remain in liver tumors for a prolonged duration, enhancing treatment efficacy.
Career Highlights
Te-Sheng Liang is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research. His work at this institution has been pivotal in advancing nuclear energy applications in medicine, particularly in cancer treatment.
Collaborations
Liang collaborates with I-Chung Tang, who is also involved in research related to cancer treatment. Their partnership exemplifies the collaborative spirit in scientific research, aiming to enhance therapeutic modalities for cancer patients.
Conclusion
Te-Sheng Liang's innovative contributions to cancer treatment through his patents highlight the potential of radioactive materials in medical applications. His work continues to pave the way for advancements in cancer therapies, showcasing the importance of innovation in healthcare.